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ABSTRACT Virulence factors are often multifunctional and contribute to pathogenesis through synergistic mechanisms. For the
human pathogen Streptococcus pyogenes, two factors that act synergistically are the S. pyogenesNAD glycohydrolase (SPN)
and streptolysin O (SLO). Through distinct mechanisms, SLO forms pores in host cell membranes and translocates SPN into the
host cell cytosol. Two natural variants of SPN exist, one that exhibits NADase activity and one that lacks this function, and both
versions are translocated and act in concert with SLO to cause an accelerated death response in epithelial cells. While NADase
SPN is known to trigger a metabolic form of necrosis through the depletion of NAD, the mechanism by which NADase SPN
induces cell death was unknown. In the studies described here, we examined the pathway of NADase cell death through analy-
sis of activation patterns of mitogen-activated protein kinases (MAPKs). S. pyogenes infection resulted in activation of members
of three MAPK subfamilies (p38, ERK, and JNK). However, only JNK was activated in an SLO-specific manner. NADase SPN
induced necrosis in HeLa epithelial cells associated with depolarization of mitochondrial membranes, activation of NF-B, and
the generation of reactive oxygen species. Remarkably, RNA interference (RNAi) silencing of JNK protected cells fromNADase-
SPN-mediated necrosis, suggesting that NADase SPN triggers a form of programmed necrosis dependent on JNK signaling.
Taken together, these data demonstrate that SPN acts with SLO to elicit necrosis through two different mechanisms depending
on its NADase activity, i.e., metabolic (NADase) or programmed (NADase), leading to distinct inflammatory profiles.
IMPORTANCE Many bacterial pathogens produce toxins that alter how infected host cells interact with the immune system. For
Streptococcus pyogenes, two toxins, a NAD glycohydrolase (SPN) and streptolysin O (SLO), act in combination to cause in-
fected cells to die. However, there are two natural forms of SPN, and these variants cause dying cells to produce different types of
signaling molecules. The NADase form of SPN kills cells by depleting reserves of NAD and cellular energy. The other form of
SPN lacks this activity (NADase); thus, the mechanism by which this variant induces toxicity was unknown. Here, we show that
infected cells recognize NADase SPN through a specific signaling molecule called JNK, which causes these cells to undergo a
form of cellular suicide known as programmed necrosis. This helps us to understand how different forms of toxins alter host cell
signaling to help S. pyogenes cause different types of diseases.
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Pore-forming toxins are perhaps the most diverse and widelydistributed class of cytotoxic proteins found among bacterial
pathogens. Their salient characteristic is an ability to interact with
and then compromise the integrity of the host cell cytoplasmic
membrane by the introduction of a transmembrane pore. This
process can lead to a number of effects important for pathogene-
sis, ranging from alteration of host cell signaling to host cell death
(for a review, see reference 1). However, despite the remarkable
alterations to host cell physiology that these toxins can produce in
cultured cells, determining the specific contribution that any sin-
gle toxin makes to virulence can be problematic.
One complication is that pore-forming toxins typically func-
tion not in isolation but rather as members of ensembles of viru-
lence factors that act in synergy to produce a cellular outcome. A
prominent example of this phenomenon involves streptolysin O
(SLO), a pore-forming toxin produced by Streptococcus pyogenes.
This Gram-positive pathogen is the causative agent of superficial
(e.g., pharyngitis and impetigo), invasive (e.g., cellulitis), and de-
structive (e.g., necrotizing fasciitis) diseases. It is also associated
with postinfection sequelae (e.g., rheumatic fever and acute glo-
merulonephritis), including certain types of tic and obsessive-
compulsive disorders in children (2–4). One difficulty in under-
standing the specific contribution that SLO makes to any of these
diseases is the fact that it acts in synergy with a second secreted
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toxin, the S. pyogenes NAD glycohydrolase (SPN, also known as
NGA). This synergy is reflected at multiple levels. First, the genes
that encode SLO and SPN are located in the same operon, and
when S. pyogenes is adherent to a host cell, both SPN and SLO are
expressed and then exported from the bacterium by the general
secretory pathway. Second, at the host cell membrane SLO facili-
tates the translocation of SPN across the membrane into the host
cell cytosol, a process called cytolysin-mediated translocation
(CMT) (5). Third, when present in an intracellular compartment,
SPN acts tomodify cellular responses that are initiated by SLO (6).
This degree of synergy renders incomplete any conclusion regard-
ing SLO’s contribution to pathogenesis that does not take into
consideration the concomitant influence of SPN.
Although the details of the CMTmechanism and how SLO and
SPN act in concert to alter host cell behaviors are not well under-
stood, numerous details of the SLO-SPN relationship have been
unraveled. For the CMT mechanism, studies have revealed that
both SLO and SPN have dedicated translocation domains that are
dispensable for their canonical functions (pore formation and
NAD cleavage, respectively) (7, 8). As an archetypicalmember of
the cholesterol-dependent cytolysin (CDC) family of hemolytic
toxins, SLO forms transmembrane pores following recognition of
cholesterol and the formation of a large oligomeric ring structure.
However, neither cholesterol binding nor oligomerization is re-
quired for CMT (8, 9). Instead, CMTproceeds from an alternative
interaction with the membrane that is codependent on SPN and
can also promote subsequent oligomerization and cholesterol-
dependent pore formation (9, 10). This suggests that the pathway
of pore formation when S. pyogenes is adherent to host cells differs
from that of the soluble toxin on bystander host cells, adding
additional complexity for understanding the role of SLO in patho-
genesis.
More recently, several studies that have examined the conse-
quences of SPN-SLO synergy have found that the cotoxins inter-
act to produce a diversity of cellular outcomes in cultured host
cells, ranging fromenhancement of intracellular survival of S. pyo-
genes in epithelial cells (11) and macrophages (12) to accelerating
killing kinetics in several types of epithelial cells (13, 14). When
these studies are compared, an additional complication is that
diversity in SPN is rarely taken into account. Population studies
have revealed that SPN exists as two distinct haplotypes, one of
which has polymorphisms at three amino acid residues that act
combinatorially to reduce its catalytic NADase efficiency 108-
fold to essentially undetectable levels (NADase SPN) (15). The
codons for these residues have signatures of positive selection, and
the NADase haplotype is associated with a degraded version of a
gene that encodes an immunity factor that is essential for expres-
sion of the NADase version of the protein (16). Together, these
data indicate that the NADase haplotypes are under strong se-
lection, implying that despite their lack of NADase activity, that
they remain essential for pathogenesis.
Studies that have conducted direct parallel comparisons of
NADase and NADase SPN have shown that both contribute to
an accelerated cytotoxic response in several types of epithelial cells
that require the pore-forming activity of SLO. A distinction is that
the steps preceding death vary between the SPN haplotypes. For
example, SLO pore formation results in hyperactivation of the
cellular enzyme poly-ADP-ribose polymerase (PARP-1), which
cleaves the same bond in NAD as NADase SPN but forms large
polymers of poly-ADP-ribose (PAR). Accumulation of PAR is
then differentiallymodified by SPN; PAR rapidly disappears in the
presence of NADase SPN but rapidly accumulates in the pres-
ence of NADase SPN (6). As a consequence, the proinflamma-
tory mediator high-mobility group Box 1 protein (HMGB1) is
released from the nucleus by a PARP-1-dependent mechanism in
response to NADase SPN but is not released during an infection
by NADase SPN strains. Instead, cells infected by these latter
strains release significantly higher levels of interleukin-8 (IL-8)
and tumor necrosis factor alpha (TNF-) (6). These differences in
outcomes illustrate why it is important to consider SPN-SLO syn-
ergy and also SPN diversity in the context of a holistic approach to
understanding how S. pyogenes interacts with host cells.
The presence or absence of SPN’s NADase activity also influ-
ences the pathway leading to cell death in epithelial cells. For
NADase SPN, cleavage of NAD results in depletion of ATP and
death by “metabolic catastrophe,” a type of unprogrammed ne-
crotic cell death that occurs when demand for cellular energy out-
strips its production (17). However, since NAD and ATP levels
are not reduced in a NADase SPN infection, it is not clear how
NADase-negative SPN contributes to cell signaling and eventually
to cell death (6).
In the present study, we took advantage of the fact that epithe-
lial cells are sensitive detectors of bacterial pore-forming toxins
and transduce pore-induced stimuli from the cellular membrane
to nuclear and other intracellular targets via members of the
highly conserved mitogen-activated protein kinase (MAPK) su-
perfamily (18). We found that infection of epithelial cells resulted
in activation of members of three prominent MAPK subfamilies
(JNK, ERK, and p38). Of these, only JNKwas activated specifically
in response to pore formation by SLO. As with NADase SPN,
infection by NADase strains resulted in death by necrosis, and
both haplotypes modified several SLO-dependent events down-
stream of JNK activation, includingmitochondrial depolarization
and production of reactive oxygen species (ROS). Significantly,
small interfering RNA (siRNA)-based knockdown of JNK pro-
tected cells from NADase SPN-induced necrotic cell death, im-
plicating JNK as a key mediator of SPN-induced cellular death.
These finding indicate that while both types of SPN cause necrosis,
they do so by divergentmechanisms, eithermetabolic (NADase)
or programmed (NADase) pathways. These data provide insight
into the mechanism of NADase cell death, how different combi-
nations of toxic activities contribute to pathogenesis, and the se-
lective pressures responsible for the adaptive radiation of SPN
enzymatic haplotypes.
RESULTS
SPN acts with SLO to cause necrosis in epithelial cells. Previ-
ously, we showed that SLO acts combinatorially with either of the
two enzymatic haplotypes of SPN to cause accelerated cell death in
HeLa cells, A549 epithelial cells, and HaCaT keratinocytes (5, 15)
and that NADase SPN causes necrosis via the process of meta-
bolic catastrophe (6). Furthermore, neither SPN variant induced
death in these cells by pyroptosis or parthanatos, two distinct
pathways of programmed necrosis (6). In order to further charac-
terize the mechanism of NADase cell death, intoxicated cells
were examined for evidence of apoptosis, a programed nonin-
flammatory pathway of cell death. Infection of HeLa cells revealed
the characteristic accelerated cell death response dependent on
both SLO and SPN, whose signature includes damage to the cel-
lular membrane (Fig. 1A). After 5 h of infection, S. pyogenes ex-
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pressing SLO in combination with either NADase or NADase
SPN resulted in the death of nearly all infected cells. In contrast,
infectionwithSLOorSPNmutants compromisedmembranes
in only 10% of cells at this time point, at a level similar to that
observed in uninfected cells (Fig. 1A). As expected, treatmentwith
staurosporine, a known inducer of apoptosis (19), also did not
compromisemembranes (Fig. 1A), although these cells did appear
to have amore rounded shape (data not shown).However, similar
to staurosporine treatment, cells infected with bacteria expressing
SLO and SPN had depolarized mitochondrial membrane poten-
tial, as determined by staining with tetramethylrhodamine ethyl
ester (TMRE) (Fig. 1A and B). Depolarization was dependent on
SLO and SPN, as mitochondrial potential was unaltered for cells
infected bySLOorSPNmutants, and these appeared similar to
uninfected cells (Fig. 1A and B). Imaging nuclear morphology by
staining with DAPI revealed that nuclear fragmentation, a hall-
mark of apoptosis (20), did not occur following infection by any
strain of S. pyogenes, although it was prominent in staurosporine-
treated cells (Fig. 1A and B). Similarly, infection did not result in
activation of the apoptosis-associated caspases (caspases 3 and 8)
activated by staurosporine (Fig. 1C). Taken together, these data
show that similar to cell death caused byNADase SPN, cell death
caused NADase SPN is by a necrotic rather than an apoptotic
mechanism.
S. pyogenes activates JNK in an SLO-dependent manner. A
variety of pore-forming toxins, including SLOhave been shown to
activate MAPKs (18, 21–23). Since MAPK activation can trigger
several pathways of programmed necrotic cell death (24, 25), in-
fected HeLa cells were examined for phosphorylation of members
of the three most prominent MAPK subfamilies, including p38,
ERK, and JNK.When cell extracts were examined using aWestern
blot analysis to probe for their activated phosphorylated forms, all
FIG 1 SPN induces necrosis. HeLa cells were infected for 5 h with the indicated strains or 1 mM staurosporine (Stauro) and then analyzed as follows. (A) Cells
were stained with the membrane-permeant dye Calcien AM and the impermeant dye ethidium homodimer-2 (Live/Dead) to assess membrane permeability
(left). Cells with intact membranes are stained green, and cells with permeabilized membranes are stained red. Cells were stained with TMRE to assess
mitochondrial membrane polarization (middle). The images are overlays of bright-field and fluorescent micrographs. Cells with mitochondria with active
membrane potential appear red. Cells were stained with DAPI to visualize nuclear fragmentation (right). Membranes and mitochondria are at a magnification
of20, and nuclei are at63. (B) Quantitation of images in panel A. Data are means and standard errors of themeans derived from 3 independent experiments
and examination of at least 1,000 total cells. (C) Cellular lysates prepared from infected monolayers were incubated with chromogenic synthetic substrates for
caspases 3 and 8, as indicated. Activation is presented as the absorbance at 405 nm. Data are means and standard deviations (SD) derived from 3 independent
experiments. *, P 0.05, **, P 0.01, and ***, P 0.001, compared to the uninfected control.
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three MAPKs were activated by S. pyogenes infection regardless of
the presence or absence of SPN (NADase SPN, NADase SPN,
and SPN) (Fig. 2A), and p38 and ERK were activated in the
absence of SLO (SLO) (Fig. 2A). However, activation of JNK
required the presence of SLO, as JNK was not activated by infec-
tion with the SLO-deficient mutant (SLO) (Fig. 2A). Pore for-
mation enhanced JNK activation, as it was not observed following
infection by a mutant that expresses an altered SLO that can bind
membrane but cannot oligomerize (Fig. 2B, Mono) and was re-
duced upon infection with amutant that expresses an SLO variant
that can oligomerize but cannot form pores (Fig. 2B, Pre). SLO
was both necessary and sufficient to activate JNK, as exposure of
HeLa cells to a range of concentrations of purified SLO activated
JNK in a concentration-dependent manner (Fig. 2C).
JNK activation is time and concentration dependent. Tran-
sient activation of JNK can protect cells from pore-forming toxins
(26), while sustained activation of JNK leads to deadly cellular
outcomes (27–29). To assess the character of JNK activation in
response to S. pyogenes, HeLa cells were infected over a range of
multiplicities of infection to determine whether there is a mini-
mum amount of bacteria needed to activate this pathway and
whether this threshold was influenced by NADase activity. Cell
lysates were prepared following 5 h of infection and analyzed as
described above, revealing that activation was still apparent when
the inoculum was reduced by approximately 50% from the stan-
dard concentration (optical density [OD]  0.5). Additionally,
cells appeared slightlymore sensitive to infection by theNADase
strain (Fig. 3). For both SPN haplotypes, JNK activation was evi-
dent at 3 h and increased until the final time point (5 h) (Fig. 3),
indicating that JNK activation is sustained in HeLa cells in re-
sponse to S. pyogenes infection.
JNK and PARP contribute to mitochondrial depolarization.
As shown above, SPN is required for mitochondrial depolariza-
tion (Fig. 1B). Since both activated JNK and PAR can be released
from the nucleus to interact with the mitochondrial membrane
and cause membrane depolarization (25, 30), we evaluated the
possibility that thesemolecules contribute to depolarization. Cells
were first treatedwith siRNAs to silence JNK1 andPARP-1, result-
ing in transfection efficiencies approaching 100% (data not
shown) and a 98% reduction of JNK1 and formation of PAR
following infection by the NADase SPN strain compared to cells
treated with control siRNA (see Fig. S1A in the supplemental ma-
terial). In addition, these treatments did not alter the efficiency of
CMT (see Fig. S1B). Activated JNK can activate PARP-1 (27);
however, this is not the case for S. pyogenes infection, as PAR was
formed in cells treated with siRNAs targeting JNK (see Fig. S1A).
Whenmitochondrial membrane potential was evaluated by stain-
ing with TMRE, cells treated with control siRNAs lost potential in
an SPN-dependent manner (Fig. 4) similar to untreated cells
(Fig. 1B). Silencing PARP-1 did not protect loss of mitochondrial
potential from infection by the NADase strain but did protect
from the NADase strain (Fig. 4), whereas silencing JNK pro-
tected mitochondrial potential from infection by both the
FIG 2 Activation of JNK requires SLO and is enhanced by pore formation.
(A)HeLa cells were infectedwith the indicated strains for 5 h, and activation of
several MAP kinases was assessed by Western blotting analyses of cellular ly-
sates to detect their phosphorylated forms. Two isoforms exist for JNK and
ERK. Lysates were compared to uninfected cells and to cells treated with stau-
rosporine (Stauro; 1 mM) and to actin. (B) Activation of JNK was assessed by
Western blotting following infection by various S. pyogenes strains expressing
NADase or NADase SPN in combination with wild-type (WT), monomer-
locked (Mono), or prepore-locked (8) SLO mutants, as indicated below the
gels. (C) Western blot analysis of JNK activation in HeLa cells following a
30-min exposure to the indicated concentrations of purified SLO. Blots pre-
sented are representative of at least 3 independent experiments. Themolecular
masses of the various proteins detected are on the right, in kilodaltons.
FIG 3 JNK activation is concentration and time dependent. Activation of
JNK was assessed by Western blotting to detect its two phosphorylated forms
in HeLa cell lysates following infection. The top and bottom panels contain
data from cells infected with NADase and NADase strains, respectively, as
indicated and are compared to actin. Concentration is represented by the
optical density of the infecting suspension of bacteria determined at 600 nm,
and lysates for all concentration experiments were prepared at 5 h postinfec-
tion. The times shown are the hours postinfection atwhich cellular lysateswere
prepared from cells infected at anOD of 0.5. Themolecular masses of proteins
detected are on the right, in kilodaltons. Data are representative of at least two
independent experiments.
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NADase and NADase strains, and in the latter case, protection
was observed in 90% of cells (Fig. 4). These data indicate that
pathways leading to depolarization are not identical between the
SPN variants, as JNK is required for NADase SPN, while NA-
Dase SPN requires both the production of PAR polymers and
activation of JNK.
SPN and SLOaffect events downstreamof JNK andPAR.Ac-
tivation of JNK and production of PAR can result in multiple
outcomes, including the production of reactive oxygen species
(ROS) and the translocation of the inflammatory-associated sig-
naling molecule NF-B from the cytoplasm into the nucleus (24,
27, 30). Immunofluorescence was used to detect nuclear translo-
cation of the NF-B p65 subunit during infection with various
S. pyogenes strains. A nuclear location could be visualized in the
majority of infected cells (~50 to 75%), irrespective of SPNor SPN
activity phenotype (Fig. 5A). The exception was infection by the
SLOmutant, in which only ~10% of cells demonstrated nuclear
translocation (Fig. 5). Similarly, staining with the fluorophore
CM-H2DCFDA to detect ROS revealed that ROS could not be
detected in cells infected with theSLOmutant but was abundant
in cells infected by strains expressing either variant of SPN
(Fig. 5A). However, unlike NF-B, the production of ROS re-
quired SPN, as infection by the SPN strain did not result the
production of ROS (Fig. 5B). These data indicate that activation of
NF-B requires SLO, while production of ROS requires both SLO
and intracellular SPN of either haplotype.
NADase cell death requires JNK activation. Since the data
presented above shows that SLO and SPN are associated with ac-
tivation of JNK and PARP-1 along with modulation of various
cellular responses downstream of activation, it was of interest to
determine the contribution of JNK and PARP-1 toNADase SPN
cell death. HeLa cells were treated with siRNAs targeting either
JNK1 or PARP-1 and infected with NADase or NADase S. pyo-
genes strains for 5 h, and then cell viability was assessed as de-
scribed above. This analysis revealed that silencing PARP-1 hadno
protective effect, with nearly all cells demonstrating compromised
membranes indistinguishable from those in cells treatedwith con-
trol siRNAs or cells that were untreated (Fig. 6). In contrast, si-
lencing JNK resulted in a significantly higher percentage of viable
cells following infection by the NADase strain than in control
treated and untreated cells and, remarkably, protected ~70% of
the cells infected by theNADase strain from cytotoxicity (Fig. 6).
These data indicate that the necrotic cell death promoted by the
NADase variant of SPN is dependent on activation of JNK1.
DISCUSSION
In this study, we have expanded our understanding of how SPN
and SLO interact to produce cellular responses that neither pro-
FIG 4 Silencing JNK and PARP inhibits NADase SPN-induced mitochondrial depolarization. (A) HeLa cells were treated with siRNA targeting JNK1 and
PARP-1 72 h prior to infectionwith the indicated strains. At 5 h postinfection, cells were stainedwith TMRE to assessmitochondrial polarization. Data aremeans
and standard errors of the means derived from 2 independent experiments and examination of at least 1,000 total cells and are compared to siRNA-treated but
uninfected cells and cells treated with siControl, consisting of a nonspecific siRNA and siGLO, an indicator of transfection efficiency (Dharmacon). **, P 0.01;
***, P 0.001.
FIG 5 ROS production, but not NF-B activation, requires SPN. HeLa cells were infected with the strains indicated for 5 h and then analyzed as follows. (A)
NF-B activationwas assessed by immunofluorescence to enumerate the nuclear translocation ofNF-Bp65 subunit compared to the number of cells where p65
is located only in the cytoplasm. (B) Staining with the fluorescent probe CM-H2DCFDA to detect the presence of reactive oxygen species (ROS). Infected cells
were compared to cell treated for 3.5 h with 1 mMH2O2. Data are means and SD derived from 3 independent experiments and the examination of at least 1,000
cells. **, P 0.01, and ***, P 0.001, compared to the uninfected control.
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duces in isolation and how their synergy is influenced by SPN
diversity. While both SPN variants cooperate with SLO to induce
an accelerated death response in HeLa cells, only the NADase
SPN, with its ability to cleave available NAD, has an obvious
function. Here, we have shown that cell death in response to the
NADase SPN involves events downstream of the SLO-mediated
activation of the c-Jun NH-terminal (JNK) MAPK. The fact that
this cell death is dependent on cellular signaling suggests that
unlike the unprogrammedmetabolic catastrophe induced byNA-
Dase SPN, JNK-dependentNADase cell death represents a cell-
directed pathway of programmed necrosis.
The involvement of JNK in cell death offers a striking example
of SLO-SPN synergy.While purified SLO and other pore-forming
toxins have been shown to activate several classes of MAPK (18,
21, 22), only JNK was specifically activated by SLO in the context
of S. pyogenes infection. The fact that purified SLO could also
activate JNK suggests that SLO is both necessary and sufficient to
trigger activation. However, this sustained activation of JNK was
not sufficient to promote accelerated cellular death, as this re-
sponse also required the presence of intracellular NADase SPN.
Interestingly, silencing JNKalso provided someprotection against
NADase SPN. Since the two SPN alleles differ at just three cata-
lytic residues and only nine residues overall (16), this suggests that
NADase SPN has dual activities, JNK-associated cell death activ-
ity and a NAD-glycohydrolase-promoted death activity. How-
ever, in the context of these infections, the data demonstrate that
the NAD-glycohydrolase-promoted cell death pathway is dom-
inant.
In contrast, themechanism by whichNADase SPN promotes
JNK-dependent death is less clear. Examination of several known
cell death-related processes revealed that mitochondrial depolar-
ization and production of ROS directly correlated with death by
SPN, suggesting that thesemay represent the convergence of JNK1
and PARP-1. Both abundant PAR and activated JNK1 can interact
with mitochondria, resulting in depolarization and the stimula-
tion of ROS production to the point of cell death (27, 31, 32).
Depending on context, activated JNK can stimulate production of
PAR (27), or conversely, accumulation of PAR can lead to activa-
tion of JNK (32). The order of these events can dictate whether
apoptosis or necrosis occurs (24, 33, 34). In the present study,
silencing either PARP-1 or JNK1 protected mitochondrial poten-
tial when cells were challenged with NADase SPN, suggesting
that the production of PAR and the activation of JNK1 are related
events in a commonpathway leading to cell death.However, other
data argue against this mechanism, including the observation that
while silencing PARP-1 protected mitochondrial membrane po-
tential, it did not protect against cell death. This indicates that
depolarization does not always lead to cell death and that PARP-1
is not an essential component of the JNK1-mediated pathway of
programmed necrosis. Consistent with this, activation of PARP-1
and that of JNK are not identical.While SLO is required to activate
both during infection, purified SLO activates JNKbut not PARP-1
(6). Thus,while PARproduction can act tomodulate cell signaling
by S. pyogenes-infected cells, PARP-1 is activated independently
from JNK (6).
The finding that signaling through JNK can trigger necrosis is
not without precedent. However, the role of JNK in cellular health
is influenced by multiple interactions in ways that are not well
understood. JNK has been implicated in protection of cells from
damage by pore-forming toxins (35) and can both inhibit and
promote apoptosis or necrosis (24). In the RIP1 kinase-dependent
pathway of programmed necrosis known as necroptosis, JNK
functions as the cellular executioner by directing the production
of toxic levels of ROS (36), possibly by the direct interaction of
activated JNK with the mitochondria (31) or by inhibition of the
cellular protective response to ROS (24). Whether JNK activation
leads to survival, apoptosis, or necrosis depends on events that
happen downstream of its activation. This is illustrated in the
present study by the fact that the SLO-directed sustained activa-
tion of JNK was not sufficient to trigger the accelerated death
response, as this also required the presence of SPN.HowSPN links
JNK to necrotic cell death remains to be determined; however, the
outcome of JNK activation can be dictated by the activation of
NF-B, which was also activated in response to SLO. NF-B can
suppress JNK-activated death-promoting processes through the
activation of genes that act as countermeasures, including genes
whose products can protect against ROS toxicity (24). This sug-
gests that SPN may function to antagonize an NF-B-activated
cellular defense that would normally support viability during sus-
tained activation of JNK. It is possible that the interaction of SPN
and SLO at themembrane contributes to perturbations leading to
inhibition of pore healing that may occur in the absence of SPN.
Production of ROS plays a central role in many JNK-
dependent pathways of cellular death. In the present study, ROS
was a specific outcome of SPN intoxication, although the dispa-
rate effects of silencing JNK and PARP-1 on cell death and mito-
chondrial depolarization cast doubt on the role of mitochondrial
membrane damage as the primary source of ROS. It should be
noted that this is not the only JNK-related pathway for ROS pro-
duction. In the version of necroptosis triggered by the cytokine
TNF-, ROS plays a central role in cell death and is produced by
the membrane-associated NADPH oxidase (NOX), which be-
comes activated by the TNF- receptor and the RIP1 kinase (37).
In this regard, it is interesting that inhibition of JNK can prevent
NOXactivation (38). Also interesting is that the TcdB cytotoxin of
Clostridium difficile produces necrosis by activation of NOX (39),
which, reminiscent of SPN, occurs independently of its canonical
glucosyltransferase enzymatic activity (40). It will be of interest to
determine if there is a common mechanism underlying TcdB-
FIG 6 Silencing of JNK, but not PARP, increases cell survival. HeLa cells were
treated with siRNAs targeting PARP-1 and JNK and after 72 h infected by a
NADase or NADase strain, as indicated, and compared to untreated cells
(no siRNA) and siControl-treated cells. Following 5 h of infection, the number
of cells that were viable was determined by fluorescence microscopy using a
vital probe (Live/Dead) as described for Fig. 1. Cells with compromised mem-
brane permeabilitywere considered nonviable. Data aremeans and SDderived
from3 independent experiments and the examination of at least 1,000 cells. **,
P 0.01; ***, P 0.001.
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induced necrosis, NOX activation, ROS toxicity, and NADase-
SPN-directed necrotic cell death.
In this study, we have shown that despite a108-fold decrease
in activity, NADase SPN is not inert but actively contributes to
mitochondrial depolarization, production of ROS, and a necrotic
cell death dependent on JNK. These data provide insight into why
NADase-negative SPN is still under positive selection and why the
NADase SPN allele has remained intact through the evolution of
this pathogen. The different death pathways induced byNADase
versus NADase SPN dictate the inflammatory profile of these
dying epithelial cells (6), which may play a role in the differential
distribution of the two variants between lineages of S. pyogenes
that differ in niche selection (16). The recent findings that Myco-
bacterium tuberculosis uses a NAD glycohydrolase to induce ne-
crotic death in infected macrophages versus apoptosis driven by
host immunity and that this results in differential modulation of
adaptive immunity (41) suggest that the use of NAD glycohy-
drolases to induce differential pathways of host cell death to ma-
nipulate signaling may be an emerging theme in pathogenesis.
How the differential signaling induced by SPN variants contrib-
utes to virulence will provide important insights into S. pyogenes
population biology and pathogenesis of its large array of different
diseases.
MATERIALS AND METHODS
Bacterial strains and media. All experiments involving S. pyogenes uti-
lized isogenic strains derived from theM serotype 6 strain JRS4 (42) (wild
type [WT]) that were engineered to express different SPN variants or to
lack expression of SPN or SLO due to in-frame deletions in the relevant
genes. These included SPNJ4 (NADase), SPNH5 (NADase), SPN
(SPN deficient), and SLO (SLO deficient). The construction of these
strains has been described in detail (15). The various SPN proteins ex-
pressed by these strains all contain a carboxy-terminal HA epitope tag
(15). Routine culture of S. pyogenes for all assays was conducted using
Todd-Hewitt medium supplemented with 0.2% yeast extract (THY me-
dium). The strains of Escherichia coli and media used for protein purifi-
cation are described below.
InfectionofHeLa cells.HeLa cells (a gift fromDongYu)were infected
using a standard method (15). Briefly, prior to infection, the various
S. pyogenes strains were inoculated into THY medium and grown over-
night at 37°C. Strains were then subcultured by inoculating 10 ml of fresh
THY medium at a dilution of 1:10 with incubation at 37°C to allow two
rounds of doubling as determined by the OD at 600 nm (OD600). Strep-
tococci were harvested by centrifugation (6,000  g for 5 min) at room
temperature, washed oncewith 10ml of phosphate-buffered saline (PBS),
and resuspended in tissue culturemedium consisting of Dulbecco’s mod-
ified Eagle medium (DMEM), 10% fetal bovine serum (FBS), 12.5 mM
glutamine, and 50 mM HEPES to an OD600 of 0.5. HeLa cells were cul-
tured in 6-well plates (Techno Plastic Products; Midsci) under the condi-
tions described previously (5) and were infected with 125 l of the strep-
tococcal suspensions, as described in detail elsewhere (15). Infections
were continued for 5 h, unless otherwise specified, and were analyzed as
described below.
Purification of SLO. Expression and purification of SLO with a
C-terminal His6 tag from E. coli followed an established method (43), as
described in detail elsewhere (44). Protein concentrations were deter-
mined using a bicinchoninic acid (BCA) assay (Pierce) with a bovine
serum albumin (BSA) standard, and purity was assessed by SDS-PAGE
and staining with Coomassie brilliant blue. Activity was verified by an
erythrocyte hemolysis assay, as described elsewhere (8). Yields were typi-
cally 4 mg protein, 95% pure, via Coomassie brilliant blue stain starting
from 300 ml of culture.
Western blot analysis. After infection, cells were washed with 10 ml
Dulbecco’s medium–phosphate-buffered saline (D-PBS), scraped, and
subjected to centrifugation (700 g, 10 min) to pellet intact cells. Super-
natants were discarded, and cells were lysed with M-PER (Thermo Scien-
tific) by incubation in the appropriate volume of reagent according to the
manufacturer’s recommendations. After 10min at room temperature, the
mixture was clarified by centrifugation (20,000 g, 10min), and aliquots
of the supernatant weremixedwith SDS loading buffer (4). The samples
were boiled for 10 min and stored at 20°C until analysis by Western
blotting as previously described (15) using the antibodies listed below.
Antibodies. Antibodies for P-JNK, P-ERK, P-p38, JNK1, and NF-B
p65 were purchased from Cell Signaling Technologies (Danvers, MA).
PAR antibody was purchased from BD Biosciences (San Jose, CA). Actin
AC-40 antibody (Sigma, St. Louis,MO)was used as a loading control. For
Western blot analyses, primary antibodies were used at a dilution of
1:1,000, and secondary horseradish peroxidase (HRP)-conjugated goat
anti-rabbit antibodies (Sigma, St. Louis, MO) were used at 1:10,000.
Caspase activation, cell permeability and cytotoxicity. Caspase acti-
vation was assessed using a colorimetric substrate assay (catalog no. ALX-
850-228; Enzo Life Sciences, Farmingdale, NY). HeLa cells were infected
for 5 h and lysed according to the manufacturer’s instructions. Briefly, 50
l of 2 reaction buffer with 10 mM dithiothreitol (DTT) was added to
50 l lysed cells followed by the addition of p-Nitroanilide-conjugated
substrates for caspases 3 and 8 to a final concentration of 200 M. Reac-
tions were developed for 1 h at 37°C, and then absorbance (405 nm) was
determined using a 96-well plate reader (M200 Infinite Pro; Tecan,
Mannedorf, Switzerland). Cell membrane integrity was assessed by visu-
alization of the ability of infected HeLa cells to exclude the membrane-
impermeant fluorescent dye ethidiumhomodimer-1 (Live/Dead; Invitro-
gen) as described previously (15). Infected cells were compared to
uninfected cells and cells treated with 1 M staurosporine (Sigma, St.
Louis, MO) for an equivalent period of time. Cells with permeable mem-
branes after 5 h of infection or treatment were considered nonviable.
Nuclear integrity, mitochondrial permeability, and reactive oxygen
species. For determination of nuclear integrity, cells were stained with
DAPI (Prolong Gold with DAPI; Invitrogen) according to the manufac-
turer’s instructions. Mitochondrial membrane potential was assessed by
staining with tetramethylrhodamine ethyl ester (TMRE; Invitrogen) di-
luted in D-PBS for a final concentration of 150 nM, as follows. Following
infection, cells were washed once with D-PBS; TMREwas then added and
incubated with the cells for 20 min at 37°C. After this time, the stain was
removed and replaced with D-PBS. For a positive depolarization of the
mitochondrial membrane, carbonyl cyanide 3-chlorophenylhydrazone
(CCCP) was used at 50 M for 1 h prior to staining. For identification of
reactive oxygen species, infected cells were washed with D-PBS and then
stained with CM-H2DCFDA (Molecular Probes) at a concentration of
1 mM in D-PBS for 15 min. Cells were washed with D-PBS and then
incubated in phenol red-free complete tissue culture medium prior to
visualization. Cells treated with all stains were imaged using a Leica
DMRE2 fluorescence microscope, and images were obtained with a Q
Imaging Retiga cooled charge-coupled device (CCD) digital camera using
Volocity software (Perkin Elmer;Waltham,MA). Infected cells were com-
pared to uninfected cells and to cells treated with H2O2 or staurosporine,
as described above.
Nuclear translocation of NF-B. Two days prior to infection, HeLa
cells were seeded in 8-well chamber slides (Lab-Tek), cultured until con-
fluent, and then infected as described above. Following infection, mono-
layers were washed with PBS and fixed with 4% paraformaldehyde for
15 min at room temperature. Fixed cells were washed twice with PBS and
then permeabilized with saponin (0.5% [vol/vol] in PBS). After three PBS
washes, cells were blockedwith PBS–T-BSA (0.1% [vol/vol] Tween 20 and
1% [vol/vol] BSA in PBS), and anti-NF-B antibody (see above) diluted
1:100 in PBS–T-BSAwas added tomonolayers and incubated overnight at
4°C. Fluorescent secondary anti-rabbit antibodies, Alexa Fluor 594 or 488
(Invitrogen) at a dilution of 1:300 was added and incubated for 2 h at
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room temperature in the dark. Cells werewashed in PBS, the chamberwas
removed, and 10 l of ProLong Gold with DAPI was placed on each
chamber square, which was overlaid with a glass slide and allowed to set
overnight. Cells were imaged by fluorescence microscopy as described
above and scored as the percentage of cells with nuclear versus cytoplas-
mic staining.
siRNA silencing of JNK and PARP. Knockdown of JNK and PARP
was performed with 100 nM of targeting siRNA duplexes (catalog no.
6232 and 6304, respectively; Cell Signaling, Inc., Danvers, MA) delivered
as lipid-siRNA complexes using Lipofectamine 2000 and Opti-MEM I
(Invitrogen) according to the manufacturer’s instructions. In parallel, si-
Control and siGLO (catalog no. D-001810-10 and D-001630-02; Dhar-
macon) at a concentration of 100 nMwere similarly complexed. By using
a reverse transfection method, complexes were added to trypsinized cells
within each well in complete tissue culture medium for 24 h, at which
point medium was replaced with fresh medium. Western blot analyses
verified knockdown compared to actin using the antibodies described
above and untreated cells with typical efficiencies of decrease of 95%.
Cells were infected 72 h after treatment.
Statistical analyses and image processing. Unless otherwise indi-
cated, data presented are means and standard errors derived from a min-
imum of three independent experiments. Differences between means
were tested for significance using the Tukey-Kramer multiple-comparison
test with the null hypothesis rejected for P values of 0.05. For image-
based data, cells were directly enumerated from captured images, and the
data presented are the means and standard errors of the means derived
from at least three independent experiments and the examination of a
minimum of 1,000 total cells. For publication, images were processed
using Adobe Photoshop CS6 and prepared using Adobe Illustrator CS6.
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